No difference seen in ongoing pregnancy versus hospital-controlled ovulation monitoring
By Lori Solomon HealthDay Reporter
THURSDAY, Sept. 14, 2023 (HealthDay News) — Home-based monitoring of ovulation is noninferior to hospital-controlled monitoring to time frozen-thawed embryo transfer (FET) for pregnancy, according to a study published online Sept. 4 in The Lancet.
Tjitske Zaat, M.D., from the University of Amsterdam, and colleagues compared ongoing pregnancy rates after home-based monitoring versus hospital-controlled monitoring with ovulation triggering. The analysis included 1,464 women (aged 18 to 44 years) with a regular ovulatory menstrual cycle who were randomly assigned (1:1) to home-based monitoring or hospital-controlled monitoring.
The researchers found that ongoing pregnancy occurred in 20.8 percent of individuals in the home-based monitoring group and in 20.9 percent in the hospital-controlled monitoring group (risk ratio [RR], 0.99; 90 percent confidence interval [CI], 0.81 to 1.22; risk difference [RD], –0.14; 90 percent CI, –3.63 to 3.36). Predetermined noninferiority was achieved (RR, 1.00; 90 percent CI, 0.81 to 1.23; RD, –0.08; 90 percent CI, –3.60 to 3.44).
“Monitoring ovulation at home means a hospital visit once for the placement of these embryos instead of three to four times for hospital monitoring,” Zaat said in a statement. “This is more sustainable and reduces the cost of treatment by up to 80 percent.”
Several authors disclosed ties to the pharmaceutical industry.
Editorial (subscription or payment may be required)
Copyright © 2023 HealthDay. All rights reserved.
